Patient has stable platelet count and haemoglobin levels with decreased symptoms after the region’s first CAR-T therapy by ...
After its success in treating blood cancers: CAR-T Therapy is now purposed to treat autoimmune disease, Lupus. -p -p ...
In a new study, researchers reviewed the advancements and ongoing challenges in the development of biologic therapies and ...
Three months after the therapy, the 60-year-old patient's platelet count and hemoglobin levels are stable, and her symptoms ...
The FDA granted fast track designation to SC291 as a potential treatment for hard-to-manage systemic lupus erythematosus (SLE).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback